Participant 1 - JRI (UK) (SME)

JRI develop innovative and novel approaches to total and partial joint replacement, with special attention to advances in the interface between the orthopaedic implant. They have an in-house regulatory and design team and manufacturing capabilities including direct access to the orthopaedic implant market. Since 1970 JRI has had a reputation for its innovation in the bone/implant interface and the development of this technology.

The developments in the ImplantDirect project will help not only maintain its market position but also help it increase share as well as getting into new geographical markets. As an SME, JRI will be involved in all stages of design as well as ensuring compliance with market regulations.